juicytore.blogg.se

Mr contrast agent
Mr contrast agent













Collagen imaging with EP-3533 can assess reduction of liver fibrosis with EDP-305 treatment in BDL rats (B-C). Peak liver signal enhancement (%ΔSI) post injection of EP-2104R is significantly higher for DEN animals compared to PBS controlsĬhemical structure of the Type I collagen-binding probes EP-3533, CM-101 and llagen1 (A). False color overlay represents subtraction image of pre-contrast image from the 1-minute post EP-2104R image. T 1-weighted axial images of rats dosed with PBS (left), with DEN and imaged 7 days after fourth DEN dose (center), and imaged 1 day after fourth DEN dose (right). EP-2104R enhanced MRI of injured rat liver ( E, Figure and caption adapted from reference ). C and D, figures and caption adapted from. Corresponding histology and immunohistochemistry (D, bottom row) show the formation of an advanced remodeled thrombus, with low signal of fibrin-specific antibody (D, bottom right) with significant expression of elastin and collagen fibers in areas adjacent to the thrombus (D, bottom left and center), indicating that remodeling took place. After 4 weeks of angiotensin II infusion, the EP-2104R enhanced MRI scan shows a weak-to-moderate signal enhancement at the location of the fibrin-rich thrombus (D, top right, red arrows). Corresponding histology (C, bottom left and center) and immunohistochemistry (C, bottom right) show the formation of a fresh fibrin-rich thrombus with a strong signal using a fibrin-specific antibody. On the EP-2104R enhanced MRI, a strong signal enhancement was measured at the location of the fibrin-rich thrombus (C, top left, red arrows).

mr contrast agent

On pre-contrast agent scans and control scans with Gd-DTPA (C and D top left and center columns), no significant enhancement was measured.

mr contrast agent

Visualization of early (2 weeks, C) and advanced/remodeled (4 weeks, D) AAA-associated thrombi by EP-2104R enhanced MRI.

mr contrast agent

T 1 relaxivity of EP-2104 R in PBS (filled triangle), in the presence of 30 μM fibrinogen (hollow circle) or in the presence of 30 μM fibrin (filled circle) (B, figure and caption adapted from ).















Mr contrast agent